Navigation Links
Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year
Date:8/10/2009

154,511 152,574 Patents, net of accumulated amortization of $172,449 as of June 30, 2009 and $135,406 as of December 31, 2008 908,571 901,045 Other assets 15,874 7,317 --------- --------- Total assets $3,715,290 $4,410,750 ========== ========== LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $1,008,710 $829,130 Accrued expenses and other payable 461,108 495,897 Line of credit-net of discount of $36,152 1,263,848 - --------- --------- Total current liabilities 2,733,666 1,325,027 --------- --------- Long-term Liabilities: Line of credit-net of discount of $52,530 - 1,247,470 Notes Payable-net of discount of $12,555 and $11,927, respectively 437,445 438,073 --------- --------- Total long-term liabilities 437,445 1,685,543 --------- --------- Commitments and Contingencies Stockholders' Equity Common stock, par value $.001; authorized 50,000,000 shares; 13,117,574 shares issued 550,093 shares to be issued and 13,084,241 shares outstanding as of June 30, 2009; 12,695,685 shares issued, 504,639 shares to be issued, and 12,662,352 shares outstanding as of December 31, 2008 13,667 13,200
'/>"/>
SOURCE Milestone Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
2. AccuVein Achieves Quality System Milestone
3. Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec
4. Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman
5. DaVitas Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland
6. BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates
7. Milestone Scientific Expands Global Sales Strategy to Enhance Penetration of International Dental Markets
8. IncentOne Achieves 2 Millionth Health Milestone
9. BD and FIND Achieve Milestone in Global Battle Against MDR-TB
10. A Milestone of Opportunity for VNUS Medical Technologies
11. StemCyte, Inc. Reaches 1,000th Cord Blood Stem Cell Shipment for Transplant Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... Javon Bea Mercy Health System CEO ... capable by the State of Illinois, enabling potential stroke ... Hospital. , The hospital was required to submit data ... stroke according to national standards of care for stroke ... bypass hospitals not designated as an Emergent Stroke Ready ...
(Date:2/28/2015)... 28, 2015 Memphis, TN: MedixSafe has ... for a new security reader named Guardian 2. ... is a new biometric scanner that significantly increases ... features, the new biometric scanner provides fast and ... , MedixSafe narcotics lockers with Vanguard ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 1Heart ... and showcased emerging brand at Houston Texas Franchise ... Las Vegas sending its executive delegates headed by ... Business Development and Training Randolph Clarito. , Franchise ... was held last February 4-7 and featured Franchise ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... Devices (IPD), has introduced miniature, wire bondable, silicon ESD ... Power LED markets. The ESD88NP and ... currents away from sensitive LED and IC products. ... Multilayer Varistors (MLV). All devices meet the requirements ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 ... “cutters”, are often misunderstood, misdiagnosed and therefore ... to healthy lives. Jacksonville-based addiction treatment ... of its highly acclaimed Lakeview Professional Lecture ... interested in understanding this complicated condition. ...
Breaking Medicine News(10 mins):Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Lakeview Health to Host Important Workshop Tackling the Rising Issue of ‘Cutters’ on March 27 2
... Association for Cancer Research and the International Association for the ... M.D., for his leadership in lung cancer research at the ... conference, held from Jan. 11-14, 2010, drew more than 300 ... and the James Dudley chair in cancer research at the ...
... control in patients with type 2 diabetes, according to ... Chicago. The study "demonstrates for the first time ... OSA severity and glucose control in patients with type ... instructor of medicine at the University of Chicago. ...
... Serious complication called empyema has doubled in young children, ... Since the PCV7 early childhood vaccine for bacterial pneumonia ... number of children hospitalized for pneumonia because of pneumococcus ... decreased overall, new research shows. , But the scientists ...
... ... source of information for dental professionals on the latest trends in restorative materials, ... ... the leading provider of online daily news and information for the dental community, ...
... ... expatriates are calling MEDEX Global Group for assistance in trying to leave the country, ASI ... members of the press into the Haitian capital, Port-au-Prince. , ... ,Baltimore, MD (Vocus) January 14, 2010 -- In the ...
... PARK, Ill., Jan. 14 A new diagnostic tool, ... a pelvic mass is benign or malignant, is now available in ... in the assessment of epithelial ovarian cancer, the most lethal form ... ARCHITECT systems, is the first automated HE4 test available ...
Cached Medicine News:Health News:Lung cancer conference leaders honor Paul A. Bunn Jr., M.D. 2Health News:Obstructive sleep apnea may worsen diabetes 2Health News:Lung Infection Up in Wake of Kids' Pneumonia Vaccine 2Health News:DrBicuspid.com Announces 3M ESPE Exclusive Sponsorship of its Restoratives Community 2Health News:DrBicuspid.com Announces 3M ESPE Exclusive Sponsorship of its Restoratives Community 3Health News:An Earthquake Emergency: MEDEX and ASI Group Quickly Respond to the Situation in Haiti 2Health News:An Earthquake Emergency: MEDEX and ASI Group Quickly Respond to the Situation in Haiti 3Health News:Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test 2
(Date:2/27/2015)... , Feb. 27, 2015  Following a bipartisan ... that moved H.R. 284, the Medicare DMEPOS Competitive ... Association for Homecare (AAHomecare) released a statement praising ... to pass the legislation. "Today,s mark-up ... House Ways and Means Committee is a critical ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 ... EPI) and Bloom Burton & Co. Ltd. ("Bloom Burton") ... lock-up (the "Lock-Up") 2,353,130 common shares of the Company ... subject to the Lock-Up. Of the Common Shares released ... immediately upon release from the Lock-Up while the remainder ...
(Date:2/27/2015)...   Synageva BioPharma Corp. (Synageva) (NASDAQ: ... therapeutic products for rare diseases, joins the National ... for Rare Diseases™ (EURORDIS™), The Global Genes Project™, ... Disease Day. On the last day ... other participants conduct special events to raise awareness ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... with investigators worldwide to develop new treatments for ... diverse forms of cancer - Plenary ... of patients with early-stage breast cancer, - Four oral sessions to feature ... study in renal cell ...
... Hispanics/Latinos, People ... with Diabetes and Obese Individuals, PARSIPPANY, N.J., ... presented at the American Society of,Hypertension,s Twenty- Third Annual ... powerful combination drug AZOR(TM),(amlodipine and olmesartan medoxomil) safely and ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism....
... offers patient monitoring products for hospital ... medium acuity monitoring. The Envoy patient ... The Enmove monitor offers a ... complement the Envoy. The Ensemble ...
... The Mayfield Triad Skull Clamp, compatible with ... visual indication of clamping force on all ... user with the possibility of adjusting the ... can easily be increased or decreased by ...
Protein-to-creatinine ratio is key to earlier detection of Kidney Disease...
Medicine Products: